| EIF5 |
EIF5: Eukaryotic translation initiation factor 5 |
POLDIP3 |
POLDIP3, KIAA1649, PDIP46: Polymerase delta-interacting protein 3 |
0.417 |
Evidence |
|
| EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
EPHA10 |
EPHA10: Ephrin type-A receptor 10 precursor |
0.417 |
Evidence |
|
| EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
AGC1 |
AGC1, CSPG1, MSK16: Aggrecan core protein precursor |
0.417 |
Evidence |
|
| EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
AGC1 |
AGC1, CSPG1, MSK16: Aggrecan core protein precursor |
0.417 |
Evidence |
|
| NTRK1 |
NTRK1, TRK: High affinity nerve growth factor receptor precursor |
EFNB3 |
EFNB3, EPLG8, LERK8: Ephrin-B3 precursor |
0.417 |
Evidence |
|
| NTRK1 |
NTRK1, TRK: High affinity nerve growth factor receptor precursor |
EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
0.417 |
Evidence |
|
| DNTT |
DNTT, TDT: DNA nucleotidylexotransferase |
MSH2 |
MSH2: DNA mismatch repair protein Msh2 |
0.417 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
0.417 |
Evidence |
|
| RPL7 |
RPL7: 60S ribosomal protein L7 |
RPL8 |
RPL8: 60S ribosomal protein L8 |
0.417 |
Evidence |
|
| PPP5C |
PPP5C, PPP5: Serine/threonine-protein phosphatase 5 |
PTGES3 |
PTGES3, P23, TEBP: Prostaglandin E synthase 3 |
0.417 |
Evidence |
|
| RGS7 |
RGS7: Regulator of G-protein signaling 7 |
GPR88 |
GPR88, STRG: Probable G-protein coupled receptor 88 |
0.417 |
Evidence |
|
| GJB1 |
GJB1, CX32: Gap junction beta-1 protein |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
0.417 |
Evidence |
|
| RAD1 |
RAD1, REC1: Cell cycle checkpoint protein RAD1 |
VCP |
VCP: Transitional endoplasmic reticulum ATPase |
0.417 |
Evidence |
|
| ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
NEK8 |
NEK8, JCK, NEK12A: Serine/threonine-protein kinase Nek8 |
0.417 |
Evidence |
|
| CSE1L |
CSE1L, CAS, XPO2: Exportin-2 |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
0.417 |
Evidence |
|
| RAB5A |
RAB5A, RAB5: Ras-related protein Rab-5A |
OSR1 |
OSR1, ODD: Protein odd-skipped-related 1 |
0.417 |
Evidence |
|
| RAB5A |
RAB5A, RAB5: Ras-related protein Rab-5A |
HNRPA2B1 |
HNRPA2B1: Heterogeneous nuclear ribonucleoproteins A2/B1 |
0.417 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
SSH2 |
SSH2, KIAA1725, SSH2L: Protein phosphatase Slingshot homolog 2 |
0.417 |
Evidence |
|
| SSRP1 |
SSRP1, FACT80: FACT complex subunit SSRP1 |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
0.415 |
Evidence |
|
| CXorf9 |
IPI00004504 |
RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
0.415 |
Evidence |
|
| EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
0.415 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
0.415 |
Evidence |
|
| RASA3 |
RASA3: Ras GTPase-activating protein 3 |
TPR |
TPR: Nucleoprotein TPR |
0.415 |
Evidence |
|
| HRB2 |
KRR1, HRB2: KRR1 small subunit processome component homolog |
Nle |
NLE1, HUSSY-07: Notchless protein homolog 1 |
0.415 |
Evidence |
|
| MGC5029 |
TRMT6, KIAA1153, TRM6: tRNA |
NRK |
NRK: Nik-related protein kinase |
0.415 |
Evidence |
|